<DOC>
	<DOCNO>NCT00335413</DOCNO>
	<brief_summary>To evaluate impact spironolactone treatment renal autoregulation hypertensive type 1 diabetic patient .</brief_summary>
	<brief_title>Autoregulation Glomerular Filtration Rate Patients With Type 1 Diabetes During Spironolactone Therapy</brief_title>
	<detailed_description>Double-masked , randomize , crossover trial . In random order , patient treat spironolactone 25 mg o.d . match placebo 28 day . On last day treatment , GFR determine twice day : first without clonidine secondly injection clonidine ( clonidine induces transient reduction blood pressure , influence renal plasma flow GFR ) , order evaluate effect antihypertensive treatment spironolactone renal autoregulation GFR . The study precede wash-out period 1 month patient receive antihypertensive medication . Patients instructed measure blood pressure twice daily , three day week period . If , washout period , blood pressure exceed 170/105 mm Hg persistent edema develop , treatment long-acting loop diuretic initiate continue throughout rest study . If blood pressure despite diuretic treatment still exceed 170 mm Hg systolic and/or 105 mm Hg diastolic , patient exclude study previous/appropriate antihypertensive treatment restart .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Type 1 diabetes Age 18 70 year Blood pressure ≥ 135 mm Hg systolic and/or ≥ 85 mm Hg diastolic ongoing antihypertensive treatment Informed consent Diabetic nephropathy Other know kidney renal tract disease Malignant hypertension Blood pressure &gt; 170/105 baseline AHT washout period Plasma potassium &gt; 4.7 mmol/l Elevated plasma creatinine ( &gt; 88 µmol/l woman &gt; 100 µmol/l men ) Symptoms Ischemic heart disease within 3 month prior study start Previous cerebrovascular event ( apoplexy , TCI ) Abuse medicine alcohol Pregnancy breastfeed Woman childbearing age use adequate contraception ASA treatment &gt; 1g/day regular use NSAIDs Known allergy sideeffects spironolactone Inability understand patient information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Renal autoregulation</keyword>
	<keyword>Glomerular filtration rate</keyword>
	<keyword>Type 1 diabetes</keyword>
</DOC>